Depakote and Anoxic encephalopathy - a phase IV clinical study of FDA data
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Depakote?
Depakote has active ingredients of divalproex sodium. It is used in bipolar disorder. Currently, eHealthMe is studying from 54,472 Depakote users.
What is Anoxic Encephalopathy?
Anoxic encephalopathy (brain damage due to lack of oxygen) is found to be associated with 707 drugs and 347 conditions by eHealthMe. Currently, we are studying 1,293 people who have Anoxic encephalopathy.
Do you take Depakote and have Anoxic encephalopathy?Check whether Anoxic encephalopathy is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Depakote side effects by duration, gender and age:
- Depakote side effects (54,472 reports)
Anoxic encephalopathy treatments and more:
- Anoxic encephalopathy (1,293 reports)
All the drugs that are associated with Anoxic encephalopathy:
All the conditions that are associated with Anoxic encephalopathy:
How the study uses the data?
The study uses data from the FDA. It is based on divalproex sodium (the active ingredients of Depakote) and Depakote (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Digoxin and Hepatitis B - 13 seconds ago
- Methotrexate Sodium and Ataxia Aggravated - 17 seconds ago
- Amlodipine and Catarrh - 18 seconds ago
- Orencia and Thrombocytopenia Aggravated - 35 seconds ago
- Rosiglitazone and Ischaemic Cardiomyopathy - 37 seconds ago
- Cinacalcet Hydrochloride and Levothyroxine Sodium drug interaction - 53 seconds ago
- Skyrizi and Appetite - Increased - 55 seconds ago
- Cyramza and Hydrochlorothiazide drug interaction - a minute ago
- Sertraline and Nuclear Magnetic Resonance Imaging Brain - a minute ago
- Tacrolimus and Tracheitis - a minute ago